Xeris Biopharma Holdings, Inc. - Common Stock — 분기별 현금 흐름 (NASDAQ:XERS) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 323.06 M392.01 M334.69 M370.19 M383.53 M 총 부채 352.68 M379 M353.99 M371.05 M369.84 M 자본금 총액 -29.61 M13.01 M-19.3 M-861 K13.69 M 총 부채 및 주주자본 323.06 M392.01 M334.69 M370.19 M383.53 M 총부채 217.01 M221.22 M218.63 M219.47 M220.34 M 순부채 217.01 M109.47 M159.34 M127.87 M109.29 M

뉴스

Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right (NASDAQ:XERS)

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Xeris Pharmaceuticals, RECORLEV 힘입어 강력한 성장세

Xeris Pharmaceuticals at Barclays: Strong Growth Fueled by RECORLEV

Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say

Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates

제리스 바이오파마, 4분기 EPS 예상치 상회 후 주가 3% 상승

Xeris Biopharma stock up nearly 3% after Q4 EPS beat, above estimate guidance

Xeris Pharmaceuticals Q1 실적, 수익 예상치를 넘어

Xeris Pharmaceuticals earnings beat by $0.04, revenue topped estimates

제리스, 성장 가속화 속 실적 시험대 올라